Home > Boards > US Listed > Medical - Drugs > MyMD Pharmaceuticals Inc (MYMD)

MYMD Scientific Update Call, in 8 minutes

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
leifsmith Member Profile
 
Followed By 58
Posts 11,953
Boards Moderated 0
Alias Born 02/09/09
160x600 placeholder
MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation Business Wire - 10/26/2021 10:30:00 AM
MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21 Business Wire - 10/19/2021 10:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:24:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:22:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:22:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:22:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/5/2021 10:00:56 AM
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7 Business Wire - 10/5/2021 10:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/22/2021 12:53:15 PM
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD Business Wire - 9/22/2021 11:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 5:31:32 PM
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan Business Wire - 9/13/2021 10:00:00 AM
MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15 Business Wire - 9/9/2021 10:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 4:38:53 PM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma Business Wire - 8/24/2021 10:17:00 AM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases Business Wire - 8/10/2021 2:30:00 PM
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine Business Wire - 8/10/2021 10:30:00 AM
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study Business Wire - 8/5/2021 10:30:00 AM
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis Business Wire - 7/27/2021 9:15:00 AM
MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1 Business Wire - 7/7/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 5:00:55 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/2/2021 4:01:25 PM
MyMD Pharmaceuticals Set to Join Russell Microcap® Index Business Wire - 6/7/2021 10:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/18/2021 6:11:59 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/18/2021 6:07:21 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences